文献速递生殖医学

人卵母细胞在卵泡最终成熟过程中体内成熟的调控

Regulation of human oocyte maturation in vivo during the final maturation of follicles.
PubMed 文献 · Hum Reprod · 2023-01-01

这项前瞻性队列研究纳入50名接受拮抗剂方案助孕的女性,在卵泡最终成熟的五个时间点采集卵泡液和颗粒细胞,评估CNP、EGF家族、抑制素、激活素、FF-MAS、MDK、GDF9和BMP15等物质及信号通路。结果显示除GDF9/BMP15外,所评估的物质和通路在体内人卵母细胞成熟调控中均有潜在活性;AREG、抑制素和MDK在启动最终成熟后12-17小时内显著上调,浓度高于既往报道;CNP浓度低且无变化,GDF9和BMP15浓度远低于小窦卵泡中的报道。

要点

  • AREG、抑制素和MDK在启动最终成熟后12-17小时内显著上调,浓度高于既往报道。
  • 调控FF-MAS合成与代谢的基因在12-17小时内显著偏向积累。
  • CNP浓度低且无变化,GDF9和BMP15浓度远低于小窦卵泡报道,提示其影响较弱。

核心结论

  • 人卵母细胞成熟的调控似乎是多因素过程,多种信号转导通路在体内有活性;除GDF9/BMP15信号外,所评估的物质和通路均有潜在活性。

研究设计与样本

  • 前瞻性队列研究,纳入50名在2016-2018年间于大学医院附属生育门诊接受标准拮抗剂方案助孕的女性。
  • 在卵泡最终成熟期间五个时间点采集卵泡液和颗粒细胞,用ELISA和蛋白质组学检测卵泡液,用全基因组基因表达分析颗粒细胞。

主要发现

  • AREG、抑制素和MDK在启动卵泡最终成熟后12-17小时内显著上调,浓度显著高于既往报道。
  • 调控FF-MAS合成与代谢的基因在12-17小时内显著受控以利于积累。
  • CNP浓度低且在整个最终成熟过程中无变化;GDF9和BMP15浓度远低于小窦卵泡中的报道。

关键数值与推荐

  • 所评估的物质和通路包括CNP、EGF家族、抑制素-A、抑制素-B、激活素、FF-MAS、MDK、GDF9和BMP15。

临床怎么用

  • 作者认为,阐明体内人卵母细胞成熟调控机制可推进IVM平台开发,使小窦卵泡卵母细胞经IVM用于生育力保存。
  • 作者认为,在IVM培养微滴中模拟体内卵母细胞成熟时的卵泡内条件可能增强卵母细胞核成熟和胞质成熟。
  • 作者认为,若小窦卵泡卵母细胞体内抽吸能有效开发,IVM可更大规模应用于不孕患者,并可能成为卵巢刺激常规IVF的廉价替代。

局限性

  • 虽然颗粒细胞和卵丘细胞有许多相似特征,但本研究无法获得对应卵丘细胞的信息,这是本研究的局限性。
  • 在卵泡抽吸的0至32小时内很少回收到卵丘-卵母细胞复合体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Which substances and signal transduction pathways are potentially active downstream to the effect of FSH and LH in the regulation of human oocyte maturation in vivo? SUMMARY ANSWER: The regulation of human oocyte maturation appears to be a multifactorial process in which several different signal transduction pathways are active. WHAT IS KNOWN ALREADY: Many studies in animal species have provided insight into the mechanisms that govern the final maturation of oocytes. Currently, these studies have identified several different mechanisms downstream to the effects of FSH and LH. Some of the identified mechanisms include the regulation of cAMP/cGMP levels in oocytes involving C-type natriuretic peptide (CNP), effects of epidermal growth factor (EGF)-related peptides such as amphiregulin (AREG) and/or epiregulin (EREG), effect of TGF-β family members including growth differentiation factor 9 (GDF9) and morphogenetic protein 15 (BMP15), activins/inhibins, follicular fluid meiosis activating sterol (FF-MAS), the growth factor midkine (MDK), and several others. However, to what extent these pathways and mechanisms are active in humans in vivo is unknown. STUDY DESIGN, SIZE, DURATION: This prospective cohort study included 50 women undergoing fertility treatment in a standard antagonist protocol at a university hospital affiliated fertility clinic in 2016-2018. PARTICIPANTS/MATERIALS, SETTING, METHODS: We evaluated the substances and signalling pathways potentially affecting human oocyte maturation in follicular fluid (FF) and granulosa cells (GCs) collected at five time points during the final maturation of follicles. Using ELISA measurement and proteomic profiling of FF and whole genome gene expression in GC, the following substances and their signal transduction pathways were collectively evaluated: CNP, the EGF family, inhibin-A, inhibin-B, activins, FF-MAS, MDK, GDF9, and BMP15. MAIN RESULTS AND THE ROLE OF CHANCE: All the evaluated substances and signal transduction pathways are potentially active in the regulation of human oocyte maturation in vivo except for GDF9/BMP15 signalling. In particular, AREG, inhibins, and MDK were significantly upregulated during the first 12-17 h after initiating the final maturation of follicles and were measured at significantly higher concentrations than previously reported. Additionally, the genes regulating FF-MAS synthesis and metabolism were significantly controlled in favour of accumulation during the first 12-17 h. In contrast, concentrations of CNP were low and did not change during the process of final maturation of follicles, and concentrations of GDF9 and BMP15 were much lower than reported in small antral follicles, suggesting a less pronounced influence from these substances. LARGE SCALE DATA: None. LIMITATIONS, REASONS FOR CAUTION: Although GC and cumulus cells have many similar features, it is a limitation of the current study that information for the corresponding cumulus cells is not available. However, we seldom recovered a cumulus-oocyte complex during the follicle aspiration from 0 to 32 h. WIDER IMPLICATIONS OF THE FINDINGS: Delineating the mechanisms governing the regulation of human oocyte maturation in vivo advances the possibility of developing a platform for IVM that, as for most other mammalian species, results in healthy offspring with good efficacy. Mimicking the intrafollicular conditions during oocyte maturation in vivo in small culture droplets during IVM may enhance oocyte nuclear and cytoplasmic maturation. The primary outlook for such a method is, in the context of fertility preservation, to augment the chances of achieving biological children after a cancer treatment by subjecting oocytes from small antral follicles to IVM. Provided that aspiration of oocytes from small antral follicles in vivo can be developed with good efficacy, IVM may be applied to infertile patients on a larger scale and can provide a cheap alternative to conventional IVF treatment with ovarian stimulation. Successful IVM has the potential to change current established techniques for infertility treatment. STUDY FUNDING/COMPETING INTEREST(S): This research was supported by the University Hospital of Copenhagen, Rigshospitalet, the Independent Research Fund Denmark (grant number 0134-00448), and the Interregional EU-sponsored ReproUnion network. There are no conflicts of interest to be declared.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Cadenas J, Poulsen LC, Nikiforov D, et al. Regulation of human oocyte maturation in vivo during the final maturation of follicles. Hum Reprod. 2023. PMID: 36762771. doi:10.1093/humrep/dead024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。